FibroGen Inc [NASDAQ: FGEN] traded at a low on Wednesday, posting a -12.24 loss after which it closed the day’ session at $5.16.
The results of the trading session contributed to over 110083 shares changing hands. Over the past one week, the price volatility of FibroGen Inc stands at 7.39% while the volatility over the past one month is 5.60%.
The market cap for FGEN stock reached $20.86 million, with 4.04 million shares outstanding and 3.76 million shares in the current float. Compared to the average trading volume of 40.27K shares, FGEN reached a trading volume of 110083 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about FibroGen Inc [FGEN]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for FGEN shares is $250.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on FGEN stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for FibroGen Inc shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on August 08, 2023. The new note on the price target was released on June 26, 2023, representing the official price target for FibroGen Inc stock.
The Average True Range (ATR) for FibroGen Inc is set at 0.68, with the Price to Sales ratio for FGEN stock in the period of the last 12 months amounting to 0.20.
How has FGEN stock performed recently?
FibroGen Inc [FGEN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -33.20. With this latest performance, FGEN shares dropped by -34.18% in over the last four-week period, additionally sinking by -38.00% over the last 6 months – not to mention a drop of -81.57% in the past year of trading.
FibroGen Inc [FGEN]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and FibroGen Inc [FGEN] shares currently have an operating margin of -29.34% and a Gross Margin at 94.59%. FibroGen Inc’s Net Margin is presently recorded at -9.73%.
Return on Equity for this stock declined to -21.86%, with Return on Assets sitting at -21.86%.
Earnings analysis for FibroGen Inc [FGEN]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for FGEN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for FibroGen Inc go to -10.06%.
Insider trade positions for FibroGen Inc [FGEN]
The top three institutional holders of FGEN stocks are: PRIMECAP MANAGEMENT CO/CA/ with ownership of 13.66 million shares, which is approximately 13.6785%. ARMISTICE CAPITAL, LLC, holding 8.94 million shares of the stock with an approximate value of $$7.97 million in FGEN stocks shares; and ARMISTICE CAPITAL, LLC, currently with $$5.25 million in FGEN stock with ownership which is approximately 5.895%.
